Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Daniel, Peter Prof. Dr. (1) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (12) Scheidereit, Claus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Specker, Edgar Dr. (1) von Kries, Jens Peter Dr. (1) (-) Janz, Martin Dr. (12) (-) Wollert-Wulf, Brigitte (2) 1999 (1) 2000 (1) 2002 (1) 2003 (3) 2004 (2) (-) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) (-) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (1) 2015 (2) 2016 (1) (-) 2017 (3) 2018 (1) 2019 (1) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) Bioinformatics and Omics Data Science (1) (-) Biology of Malignant Lymphomas (12) Cellular Neurosciences (1) Computational Regulatory Genomics (2) Developmental Biology / Signal Transduction (2) Epigenetic Regulation and Chromatin Architecture (1) Genetics and Genomics of Cardiovascular Diseases (2) Integrative Vascular Biology (1) Molecular Immunology and Gene Therapy (2) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (2) Proteome Dynamics (18) Psychoneuroimmunology (1) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (2) Systems Biology Imaging (1) Systems Biology of Gene Regulatory Elements (1) Translational Bioinformatics (4) 12 Results: Active Filter: Janz, Martin Dr.Wollert-Wulf, BrigitteBiology of Malignant Lymphomas2005200620092017 Sort: Result score Newest to oldest Oldest to newest October 29, 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch September 01, 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch April 07, 2009 / Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken Pagination Current page 1 Page 2 Next page Next › Last page Last »
October 29, 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch
September 01, 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz
March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
April 07, 2009 / Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken
August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken